The effect of the dexamethasone, cytarabine, and cisplatin (DHAP) regimen on stem cell mobilization and transplant outcomes of patients with non-Hodgkin’s lymphoma who are candidates for up-front autologous stem cell transplantation

BACKGROUND/AIMS: Data on dexamethasone, cytarabine, and cisplatin (DHAP) as a mobilization regimen, compared to high-dose cyclophosphamide (HDC), for up-front autologous stem cell transplantation (ASCT) in non-Hodgkin’s lymphoma (NHL) is limited. METHODS: Consecutive patients with aggressive NHL tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, So Yeon, Yhim, Ho-Young, Kim, Hee Sun, Kim, Jeong-A, Yang, Deok-Hwan, Kwak, Jae-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234385/
https://www.ncbi.nlm.nih.gov/pubmed/29295612
http://dx.doi.org/10.3904/kjim.2016.163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234385/
https://www.ncbi.nlm.nih.gov/pubmed/29295612
http://dx.doi.org/10.3904/kjim.2016.163

Ejemplares similares